SUDA Pharmaceuticals Ltd (ASX:SUD), a leader in oro-mucosal drug delivery, is pleased to announce ZolpiMist Clinical Study Results Demonstrating Lingual Spray Delivers More Rapid Sleep Onset Compared to Tablet Form of Zolpidem Based on Efficacy Parameters and Pharmacokinetics.
For more information, download the attached PDF.
Download this document
